{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:24:57Z","timestamp":1787239497588,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A multidisciplinary team meeting (MDM) approach in breast cancer (BC) management is a standard of care. One of the roles of MDMs is to identify the best diagnostic and therapeutic strategies for patients (pts) with new diagnosis of early BC. The purpose of this study was to define whether there was an agreement between the planned program (i.e., MDMs-based decision) and that actually applied. In addition, the study explored factors associated with discordance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of a consecutive series of 291 patients with new diagnosis of early BC, discussed at MDMs at the University Hospital of Udine (Italy), from January 2017 to June 2018. The association between clinico-biological factors and discordance between what was decided during the MDMs and what was consequently applied by the oncologist was explored through uni- and multivariate logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age was 62 years (range 27\u201388 years). Among invasive early BC patients, the most frequent phenotype was luminal A (38%), followed by luminal B (33%), HER2-positive (12%), and triple-negative (5%).\n                      <jats:italic>In situ<\/jats:italic>\n                      carcinoma (DCIS) represented 12% of cases. The median time from MDM discussion to first oncologic examination was 2 weeks. The rate of discordance between MDM-based decision and final choice, during a face-to-face consultation with the oncologist, was 15.8% (46\/291). The most frequent reason for changing the MDM-based program was clinical decision (87%). Follow-up was preferred to the chemotherapy (CT) proposed within the MDMs in 15% of cases, and to the endocrine therapy (ET) in 39% of cases (among these, 44.5% had a diagnosis of DCIS). Therapeutic change from sequential CT-ET to ET alone was chosen in 16\/46 pts (35%): among these patients, seven had a luminal B disease and six had an HER2-positive disease. On univariate analysis, factors associated with discordance were values of Ki-67 14%\u201330% (OR 3.91; 95% CI 1.19\u201312.9), age\n                      <jats:underline>&amp;gt;<\/jats:underline>\n                      70 years (OR 2.44, 95% CI 1.28\u20134.63), housewife\/retired status (OR 2.35, 95% CI 1.14\u20134.85), polypharmacy (OR 1.95; 95% CI 1.02\u20133.72), postmenopausal status (OR 4.15; 95% CI 1.58\u201310.9), and high Charlson Comorbidity Index (OR 1.31; 95% CI 1.09\u20131.57). The association with marital status, educational level, alcohol and smoke habits, presence of a caregiver, parity, grading, histotype and phenotype, and stage was not statistically significant. On multivariate analysis, only Ki-67 value maintained its statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of our study could be useful for enhancing the role of MDMs in the clinical decision-making process in early BC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2022.885992","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:49:58Z","timestamp":1654562998000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?"],"prefix":"10.3389","volume":"12","author":[{"given":"Lucia","family":"Bortot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Targato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Giavarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Palmero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Zara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Andreetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Pascoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Seriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Mansutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cedolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bonotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Marco","family":"Minisini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0002","article-title":"Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario","volume":"19","author":"Bonotto","year":"2014","journal-title":"Oncologist"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz173","article-title":"Early Breast Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.10.023","article-title":"European Breast Cancer Conference Manifesto on Breast Centres\/Units","volume":"72","author":"Cardoso","year":"2017","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.breast.2020.02.003","article-title":"The Requirement of a Specialist Breast Centre","volume":"51","author":"Briganzoli","year":"2020","journal-title":"Breast"},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amjoto.2012.08.010","article-title":"Multidisciplinary Clinic Care Improves Adherence to Best Practice in Head and Neck Cancer","volume":"34","author":"Kelly","year":"2013","journal-title":"Am J Otolaryng"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e318243708f","article-title":"Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines: The William Beaumont Hospital Experience","volume":"20","author":"Korman","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2008.01580.x","article-title":"Improving Patient Survival With the Colorectal Cancer Multi-Disciplinary Team","volume":"11","author":"MacDermid","year":"2009","journal-title":"Colorectal Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3413-8","article-title":"Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated With Improved Clinical Outcome","volume":"21","author":"Yopp","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602825","article-title":"An Evaluation of the Impact of a Multidisciplinary Team, in a Single Centre, on Treatment and Survival in Patients With Inoperable Non-Small-Cell Lung Cancer","volume":"93","author":"Forrest","year":"2005","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26149","article-title":"Do Multidisciplinary Team Meetings Make a Difference in the Management of Lung Cancer","volume":"117","author":"Boxer","year":"2011","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2380::AID-CNCR12>3.0.CO;2-N","article-title":"Multidisciplinary Breast Cancer Clinics: Do They Work","volume":"79","author":"Gabel","year":"1997"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0399-8320(07)89375-4","article-title":"Place of Multidisciplinary Consulting Meetings and Clinical Trials in the Management of Colorectal Cancer in France in 2000","volume":"31","author":"Bouvier","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","article-title":"The Impact of Multidisciplinary Team Meetings on Patient Assessment, Management and Outcomes in Oncology Settings: A Systematic Review of the Literature","volume":"42","author":"Pillay","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejcts.2010.01.051","article-title":"The Effect of a Multidisciplinary Thoracic Malignancy Conference on the Treatment of Patients With Lung Cancer","volume":"38","author":"Freeman","year":"2010","journal-title":"Eur J Cardio Thorac Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70203-8","article-title":"The Multidisciplinary Melanoma Clinic: A Cost Outcomes Analysis of Specialty Care","volume":"38","author":"Fader","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr352","article-title":"Role of the Multidisciplinary Team in Breast Cancer Management: Results From a Large International Survey Involving 39 Countries","volume":"23","author":"Saini","year":"2012","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1211e9","DOI":"10.1093\/annonc\/mds642","article-title":"Adjuvant Chemo- Therapy in Elderly Women With Breast Cancer (AChEW): An Observational Study Identifying MDT Perceptions and Barriers to Decision Making","volume":"24","author":"Ring","year":"2013","journal-title":"Ann Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2011.07.008","article-title":"Characteristics and Outcomes According to Molecular Subtypes of Breast Cancer as Classified by a Panel of Four Biomarkers Using Immunohistochemistry","volume":"21","author":"Park","year":"2012","journal-title":"Breast"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/BCTT.S35581","article-title":"Benefits of Multidisciplinary Teamwork in the Management of Breast Cancer","volume":"5","author":"Taylor","year":"2013","journal-title":"Breast Cancer Targets Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/831605","article-title":"Cancer Multidisciplinary Team Meetings: Evidence, Challenges, and the Role of Clinical Decision Support Technology, Int","volume":"2011","author":"Patkar","year":"2011","journal-title":"J Breast Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.4713","article-title":"\u201cMultidisciplinary Care of Breast Cancer Patients: A Scoping Review of Multidisciplinary Styles, Processes, and Outcomes,\u201d","volume":"26","author":"Shao","year":"2019","journal-title":"Curr Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.189","article-title":"\u201cPractice Patterns of Multidisciplinary Team Meetings in Korean Cancer Care and Patient Satisfaction With This Approach,\u201d","volume":"35","author":"Maeng","year":"2020","journal-title":"Korean J Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj102","article-title":"Analysis of Clinical Decision-Making in Multi-Disciplinary Cancer Teams","volume":"17","author":"Blazeby","year":"2006","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2007.01464.x","article-title":"\u201cAn Evaluation of Treatment Decisions at a Colorectal Cancer Multi-Disciplinary Team,\u201d","volume":"10","author":"Wood","year":"2008","journal-title":"Color Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv025","article-title":"\u201cConsideration of Comorbidity in Treatment Decision Making in Multidisciplinary Cancer Team Meetings: A Systematic Review,\u201d","volume":"26","author":"Stairmand","year":"2015","journal-title":"Ann Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.critrevonc.2010.06.005","article-title":"Adjuvant Chemotherapy in Elderly Patients With Early Breast Cancer. Impact of Age and Comprehensive Geriatric Assessment on Tumor Board Proposals","volume":"79","author":"Barth\u00e9l\u00e9my","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2019.06.001","article-title":"Multidisciplinary Team Meeting and EUSOMA Quality Indicators in Breast Cancer Care: A French Regional Multicenter Study","volume":"46","author":"Pons-Tostivint","year":"2019","journal-title":"Breast"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4174\/jkss.2012.82.6.340","article-title":"\u201cMultidisciplinary Team Approach in Breast Cancer: A Nationwide Survey in Korea,\u201d","volume":"82","author":"Chae","year":"2012","journal-title":"J Korean Surg Soc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the Treatment of Women With Early Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.885992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:50:00Z","timestamp":1654563000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.885992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":32,"alternative-id":["10.3389\/fonc.2022.885992"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.885992","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"article-number":"885992"}}